Nascent Biotech Inc. (NBIO)
OTHER OTC:NBIO
US Market
Holding NBIO?
Track your performance easily

Nascent Biotech (NBIO) Financial Statements

35 Followers

Nascent Biotech Financial Overview

Nascent Biotech's market cap is currently ―. The company's EPS TTM is $-0.012; its P/E ratio is -4.67; Nascent Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit$ -114.63K$ -454.33K-$ 136.51K-
EBIT$ -375.44K$ -490.08K$ -704.35K$ 35.39K$ -2.42M
EBITDA$ -375.44K$ -490.08K$ -704.35K$ 267.77K$ -2.04M
Net Income Common Stockholders$ -377.39K$ -512.58K$ -829.48K$ -540.22K$ -2.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 9.48K$ 172.19K
Total Assets$ 227.39K$ 552.12K$ 1.04M$ 78.92K$ 255.00K
Total Debt$ 59.00K$ 122.50K$ 305.00K$ 276.97K$ 389.59K
Net Debt$ 59.00K$ 122.50K$ 305.00K$ 267.49K$ 217.41K
Total Liabilities$ 741.93K$ 808.79K$ 1.05M$ 1.23M$ 1.55M
Stockholders Equity$ -514.54K$ -256.67K$ -6.41K$ -1.16M$ -1.30M
Cash Flow-
Free Cash Flow$ -324.73K$ -351.73K$ -341.51K$ -162.71K$ -386.58K
Operating Cash Flow$ -324.73K$ -351.73K$ -341.51K$ -162.71K$ -386.58K
Investing Cash Flow-----
Financing Cash Flow-$ 100.00K$ 1.34M--
Currency in USD

Nascent Biotech Earnings and Revenue History

Nascent Biotech Debt to Assets

Nascent Biotech Cash Flow

Nascent Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis